HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Is the early-onset torsion dystonia (EOTD) linked to TOR1A gene as frequent as expected in France?

Abstract
Early onset torsion dystonia are rare movement disorders. Molecular defect is known for only a subgroup, consisting of a unique and recurrent mutation in the TOR1A gene. We undertook a nationwide census of French TOR1A-mutation carriers and the assessment of clinical associated signs. Overall, 53 index cases and 104 relatives were studied and haplotypes linked to the mutation constructed. The previously reported Ashkenazi-Jewish haplotype was found in 11 families with the remainder carrying distinct haplotypes suggesting independent mutation events. This study demonstrates the scarcity of this disease in France with estimated disease frequency of 0.13:100,000 and mutation frequency of 0.17:100,000.
AuthorsM Y Frédéric, F Clot, L Cif, A Blanchard, A Dürr, I Vuillaume, G Lesca, A Kreisler, C Davin, T Besnard, F Rousset, D Thorel, C Saquet, D Mechin, L Ozelius, Y Agid, B Barroso, B Chabrol, V Chan, M Clanet, C Coubes, A Destee, K Nguyen, C Vial, M Vidailhet, J Xie, B Sablonniere, A Calender, A Brice, A Roubertie, P Coubes, M Claustres, S Tuffery-Giraud, G Collod-Beroud
JournalNeurogenetics (Neurogenetics) Vol. 9 Issue 2 Pg. 143-50 (May 2008) ISSN: 1364-6753 [Electronic] United States
PMID18322712 (Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
Chemical References
  • Molecular Chaperones
  • TOR1A protein, human
Topics
  • Adolescent
  • Age of Onset
  • Case-Control Studies
  • Child
  • Dystonia Musculorum Deformans (genetics)
  • Female
  • France
  • Gene Frequency
  • Genetic Linkage
  • Haplotypes
  • Heterozygote
  • Humans
  • Jews (genetics)
  • Male
  • Molecular Chaperones (genetics)
  • Phenotype
  • Sequence Deletion

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: